JP2022046676A5 - - Google Patents

Download PDF

Info

Publication number
JP2022046676A5
JP2022046676A5 JP2021212106A JP2021212106A JP2022046676A5 JP 2022046676 A5 JP2022046676 A5 JP 2022046676A5 JP 2021212106 A JP2021212106 A JP 2021212106A JP 2021212106 A JP2021212106 A JP 2021212106A JP 2022046676 A5 JP2022046676 A5 JP 2022046676A5
Authority
JP
Japan
Prior art keywords
growth factor
protein
factor
therapeutic protein
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021212106A
Other languages
English (en)
Japanese (ja)
Other versions
JP7258999B2 (ja
JP2022046676A (ja
Filing date
Publication date
Priority claimed from JP2020196260A external-priority patent/JP7054407B2/ja
Application filed filed Critical
Publication of JP2022046676A publication Critical patent/JP2022046676A/ja
Publication of JP2022046676A5 publication Critical patent/JP2022046676A5/ja
Application granted granted Critical
Publication of JP7258999B2 publication Critical patent/JP7258999B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021212106A 2010-07-30 2021-12-27 オキシム連結のための求核触媒 Active JP7258999B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36918610P 2010-07-30 2010-07-30
US61/369,186 2010-07-30
JP2020196260A JP7054407B2 (ja) 2010-07-30 2020-11-26 オキシム連結のための求核触媒

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020196260A Division JP7054407B2 (ja) 2010-07-30 2020-11-26 オキシム連結のための求核触媒

Publications (3)

Publication Number Publication Date
JP2022046676A JP2022046676A (ja) 2022-03-23
JP2022046676A5 true JP2022046676A5 (cg-RX-API-DMAC7.html) 2022-06-03
JP7258999B2 JP7258999B2 (ja) 2023-04-17

Family

ID=44629987

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2013521998A Active JP6325818B2 (ja) 2010-07-30 2011-07-29 オキシム連結のための求核触媒
JP2015118007A Withdrawn JP2015164958A (ja) 2010-07-30 2015-06-11 オキシム連結のための求核触媒
JP2017099807A Withdrawn JP2017137358A (ja) 2010-07-30 2017-05-19 オキシム連結のための求核触媒
JP2019064338A Withdrawn JP2019116501A (ja) 2010-07-30 2019-03-28 オキシム連結のための求核触媒
JP2019064337A Active JP6757823B2 (ja) 2010-07-30 2019-03-28 オキシム連結のための求核触媒
JP2020196260A Active JP7054407B2 (ja) 2010-07-30 2020-11-26 オキシム連結のための求核触媒
JP2021212106A Active JP7258999B2 (ja) 2010-07-30 2021-12-27 オキシム連結のための求核触媒

Family Applications Before (6)

Application Number Title Priority Date Filing Date
JP2013521998A Active JP6325818B2 (ja) 2010-07-30 2011-07-29 オキシム連結のための求核触媒
JP2015118007A Withdrawn JP2015164958A (ja) 2010-07-30 2015-06-11 オキシム連結のための求核触媒
JP2017099807A Withdrawn JP2017137358A (ja) 2010-07-30 2017-05-19 オキシム連結のための求核触媒
JP2019064338A Withdrawn JP2019116501A (ja) 2010-07-30 2019-03-28 オキシム連結のための求核触媒
JP2019064337A Active JP6757823B2 (ja) 2010-07-30 2019-03-28 オキシム連結のための求核触媒
JP2020196260A Active JP7054407B2 (ja) 2010-07-30 2020-11-26 オキシム連結のための求核触媒

Country Status (26)

Country Link
EP (3) EP2598172B1 (cg-RX-API-DMAC7.html)
JP (7) JP6325818B2 (cg-RX-API-DMAC7.html)
KR (6) KR102229967B1 (cg-RX-API-DMAC7.html)
CN (3) CN108079312A (cg-RX-API-DMAC7.html)
AR (1) AR082941A1 (cg-RX-API-DMAC7.html)
AU (1) AU2011282571C1 (cg-RX-API-DMAC7.html)
BR (1) BR112013001611B1 (cg-RX-API-DMAC7.html)
CA (1) CA2806684C (cg-RX-API-DMAC7.html)
CY (1) CY1121943T1 (cg-RX-API-DMAC7.html)
DK (1) DK2598172T3 (cg-RX-API-DMAC7.html)
EA (2) EA025738B9 (cg-RX-API-DMAC7.html)
ES (1) ES2731626T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20190990T1 (cg-RX-API-DMAC7.html)
HU (1) HUE043790T2 (cg-RX-API-DMAC7.html)
LT (1) LT2598172T (cg-RX-API-DMAC7.html)
MX (1) MX346271B (cg-RX-API-DMAC7.html)
NZ (1) NZ605972A (cg-RX-API-DMAC7.html)
PL (1) PL2598172T3 (cg-RX-API-DMAC7.html)
PT (1) PT2598172T (cg-RX-API-DMAC7.html)
RS (1) RS58900B1 (cg-RX-API-DMAC7.html)
SG (2) SG187171A1 (cg-RX-API-DMAC7.html)
SI (1) SI2598172T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201900351T1 (cg-RX-API-DMAC7.html)
TR (1) TR201908836T4 (cg-RX-API-DMAC7.html)
TW (1) TWI534152B (cg-RX-API-DMAC7.html)
WO (1) WO2012016131A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
TWI534152B (zh) * 2010-07-30 2016-05-21 巴克斯特國際公司 用於肟連接的親核性催化劑
ES2800983T3 (es) 2010-12-22 2021-01-07 Baxalta GmbH Materiales y métodos para conjugar un derivado de ácido graso soluble en agua con una proteína
HK1200695A1 (en) * 2012-04-16 2015-08-14 Cantab Biopharmaceuticals Patents Limited Optimised subcutaneous therapeutic agents
AU2013204754C1 (en) * 2012-05-16 2018-10-11 Takeda Pharmaceutical Company Limited Nucleophilic Catalysts for Oxime Linkage
MA39711A (fr) * 2014-04-03 2015-10-08 Nektar Therapeutics Conjugués d'une fraction d'il-15 et d'un polymère
WO2017062832A1 (en) 2015-10-08 2017-04-13 Nektar Therapeutics Combination of an il-2rbeta-selective agonist and a long-acting il-15 agonist
TW201731869A (zh) * 2015-12-03 2017-09-16 百克莎塔股份有限公司 具有延長之半衰期及降低之配位體結合性質的因子viii
WO2018017923A1 (en) * 2016-07-22 2018-01-25 Nektar Therapeutics Conjugates of a factor viii moiety having an oxime-containing linkage
KR20250057110A (ko) 2017-05-15 2025-04-28 넥타르 테라퓨틱스 지속 작용성 인터류킨-15 수용체 효현제 및 관련 면역요법 조성물 및 방법
CA3126476A1 (en) 2019-01-23 2020-07-30 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors
US11845989B2 (en) 2019-01-23 2023-12-19 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
WO2022182768A1 (en) 2021-02-26 2022-09-01 Regeneron Pharmaceuticals, Inc. Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (angptl7) inhibitors
WO2025133203A1 (en) * 2023-12-22 2025-06-26 Pam Theragnostics Gmbh Compounds and methods for a long-lasting pam

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54113492A (en) 1978-02-24 1979-09-05 Sanyo Chem Ind Ltd Preparation of glucoprotein derivative
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4757006A (en) 1983-10-28 1988-07-12 Genetics Institute, Inc. Human factor VIII:C gene and recombinant methods for production
US5198349A (en) 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
US5250421A (en) 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
JPH0387173A (ja) 1987-09-10 1991-04-11 Teijin Ltd ヒト活性化天然型ファクター8cの製造方法及びそれに用いる形質転換体
US5846951A (en) 1991-06-06 1998-12-08 The School Of Pharmacy, University Of London Pharmaceutical compositions
ATE198277T1 (de) 1992-10-02 2001-01-15 Genetics Inst Zusammensetzung, welche den koagulationsfaktor viii beinhaltet; verfahren zu deren herstellung und die benutzung eines oberflächenaktiven stoffes als stabilisator
WO1994028024A1 (en) * 1993-06-01 1994-12-08 Enzon, Inc. Carbohydrate-modified polymer conjugates with erythropoietic activity
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
US5574187A (en) * 1994-10-06 1996-11-12 Uniroyal Chemical Company, Inc. Process of preparing para substituted phenylamines
WO1996040662A2 (en) 1995-06-07 1996-12-19 Cellpro, Incorporated Aminooxy-containing linker compounds and their application in conjugates
WO1999003496A1 (en) 1997-07-21 1999-01-28 The University Of North Carolina At Chapel Hill Factor ix antihemophilic factor with increased clotting activity
US7074878B1 (en) 1999-12-10 2006-07-11 Harris J Milton Hydrolytically degradable polymers and hydrogels made therefrom
US6413507B1 (en) 1999-12-23 2002-07-02 Shearwater Corporation Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
AU2001258536A1 (en) 2000-05-16 2001-11-26 Lipoxen Technologies Limited Derivatisation of proteins in aqueous solution
US7265084B2 (en) 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
EP1446438A2 (en) 2001-11-07 2004-08-18 Nektar Therapeutics Al, Corporation Branched polymers and their conjugates
MXPA05002594A (es) 2002-09-11 2005-05-27 Fresenius Kabi Gmbh Derivados de polipeptidos con hidroxialquilalmidon, especialmente derivados de eritropoyetina con hidroxialquilalmidon.
WO2004089280A2 (en) 2003-04-08 2004-10-21 Yeda Research And Development Co. Ltd. Reversible pegylated drugs
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
TWI356065B (en) * 2003-08-08 2012-01-11 Fresenius Kabi De Gmbh Method of producing hydroxyalkyl starch derivative
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
WO2005014024A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of a polymer and a protein linked by an oxime linking group
EP1654290B1 (en) 2003-08-12 2019-03-13 Lipoxen Technologies Limited Sialic acid derivatives for protein derivatisation and conjugation
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
ES2422187T3 (es) 2003-12-03 2013-09-09 Biogenerix Ag Factor estimulante de colonias de granulocitos glicopegilados
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
EP1776389B1 (en) 2004-08-12 2016-06-29 Lipoxen Technologies Limited Sialic acid derivatives
WO2006031811A2 (en) 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
AU2005322067B8 (en) 2004-12-27 2012-07-26 Takeda Pharmaceutical Company Limited Polymer-von Willebrand factor-conjugates
CA2611823C (en) 2005-06-16 2013-07-30 Nektar Therapeutics Al, Corporation Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
US7645860B2 (en) * 2006-03-31 2010-01-12 Baxter Healthcare S.A. Factor VIII polymer conjugates
CN101535339B (zh) * 2006-09-01 2014-11-12 诺沃-诺迪斯克保健股份有限公司 改性糖蛋白
US20100056428A1 (en) * 2006-09-01 2010-03-04 Novo Nordisk Health Care Ag Modified proteins
DK2101821T3 (da) 2006-12-15 2014-10-06 Baxter Healthcare Sa Faktor VIIA-(poly)sialinsyre-konjugat med forlænget halveringstid in vivo
EP2201953A4 (en) * 2007-08-27 2011-08-03 Univ Nagoya Nat Univ Corp USE OF RIBAVIRIN IN BLOOD CLEANING DISORDERS
GB0908393D0 (en) * 2009-05-15 2009-06-24 Almac Sciences Scotland Ltd Labelling method
EP3081233B1 (en) * 2009-07-27 2020-12-23 Baxalta GmbH Glycopolysialylation of proteins other than blood coagulation proteins
BR112012001814A8 (pt) * 2009-07-27 2018-02-06 Baxalta GmbH Conjugados de proteína de coagulação sanguínea
EA201290069A1 (ru) * 2009-07-31 2012-07-30 Байер Хелскер Ллс Модифицированные полипептиды фактора ix и их применения
TWI534152B (zh) * 2010-07-30 2016-05-21 巴克斯特國際公司 用於肟連接的親核性催化劑

Similar Documents

Publication Publication Date Title
JP2022034075A5 (cg-RX-API-DMAC7.html)
JP2020111599A5 (cg-RX-API-DMAC7.html)
JP2019116500A5 (cg-RX-API-DMAC7.html)
JP2015520163A5 (cg-RX-API-DMAC7.html)
JP2019089810A5 (cg-RX-API-DMAC7.html)
JP3497175B2 (ja) 一価の(monovalent)抗体フラグメント
HRP20190990T1 (hr) Nukleofilni katalisti za vezanje oksima
JP5419689B2 (ja) 顆粒球コロニー刺激因子の誘導体化
Kochendoerfer Site-specific polymer modification of therapeutic proteins
JP5336372B2 (ja) G−csf部位特異的モノコンジュゲート
US8378073B2 (en) Process for attaching effector molecules to proteins
JP2013536180A5 (cg-RX-API-DMAC7.html)
JP2001526238A (ja) 実質的に純粋なヒスチジン結合タンパク質−ポリマー結合体
JPWO1990006952A1 (ja) 化学修飾顆粒球コロニー刺激因子
JP2009096810A (ja) 成長ホルモンおよび関連タンパク質の誘導体
JP2007532098A (ja) 免疫グロブリン不変領域の量産方法
JP2007533665A (ja) 新規g−csf結合体
EP1128847A1 (en) Antibody-serum protein hybrids
JP2022034075A (ja) オキシム連結のための求核触媒
JP5349501B2 (ja) セレン含有改質剤及びコンジュゲート(Conjugates)
JP2007528347A (ja) 延長された生体内半減期を有するpeg−生理活性ポリペプチド同種二量体結合体及びその製造方法
WO2009113743A1 (ja) Peg化ラクトフェリン複合体及びその製造方法
JPWO1996010089A1 (ja) ペプチド及び蛋白質の修飾
Zvonova et al. Strategies for modulation of pharmacokinetics of recombinant therapeutic proteins
WO1992014832A1 (fr) Procedes pour la purification de fdlb humains